Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.
about
Invariant NKT cells as novel targets for immunotherapy in solid tumorsIdentification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunityCalreticulin controls the rate of assembly of CD1d molecules in the endoplasmic reticulumLiver autoimmunity triggered by microbial activation of natural killer T cellsThe role of NKT cells in tumor immunityHow do natural killer T cells help B cells?Autoimmune disease triggered by infection with alphaproteobacteriaStructure and function of a potent agonist for the semi-invariant natural killer T cell receptorDoes an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?Recognition of Microbial Glycolipids by Natural Killer T CellsCD1d- and MR1-Restricted T Cells in SepsisCoevolution of T-cell receptors with MHC and non-MHC ligandsThe Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell GenerationiNKT Cells and Their Potential Lipid Ligands during Viral InfectionTurned on by danger: activation of CD1d-restricted invariant natural killer T cellsImmunological cells and functions in Gaucher diseaseBacterial lipids: metabolism and membrane homeostasisThe functions of type I and type II natural killer T cells in inflammatory bowel diseasesT cell recognition of non-peptidic antigens in infectious diseasesRole of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune responseStages versus subsets: Invariant Natural Killer T cell lineage differentiationModulatory function of invariant natural killer T cells in systemic lupus erythematosusThe regulatory role of invariant NKT cells in tumor immunityRole of non-conventional T lymphocytes in respiratory infections: the case of the pneumococcusInvariant natural killer T cell agonist modulates experimental focal and segmental glomerulosclerosisEndoplasmic reticulum aminopeptidase-1 functions regulate key aspects of the innate immune responseEBV promotes human CD8 NKT cell developmentNKT cell-TCR expression activates conventional T cells in vivo, but is largely dispensable for mature NKT cell biologyActivation of invariant NKT cells exacerbates experimental visceral leishmaniasisMAIT cells detect and efficiently lyse bacterially-infected epithelial cellsTLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasisDifferential Recognition of CD1d-α-Galactosyl Ceramide by the Vβ8.2 and Vβ7 Semi-invariant NKT T Cell ReceptorsCrystal Structures of Mouse CD1d-iGb3 Complex and its Cognate Vα14 T Cell Receptor Suggest a Model for Dual Recognition of Foreign and Self GlycolipidsLipid binding orientation within CD1d affects recognition of Borrelia burgorferi antigens by NKT cellsThe Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding modeA Molecular Basis for NKT Cell Recognition of CD1d-Self-AntigenA semi-invariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition propertiesInvariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteriaV 2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigenUnique Interplay between Sugar and Lipid in Determining the Antigenic Potency of Bacterial Antigens for NKT Cells
P2860
Q21284987-7111A51A-DC70-4A64-9918-8F92E3C06C8CQ24633643-F5175756-FCCD-4F02-94D7-137F2EB00720Q24634393-D25C4979-7FCE-44DB-B842-010E85987EEDQ24644772-5CEDA1BA-CC50-4A8B-8992-1F97E32144E3Q24648939-15671063-3991-4E33-A244-AD80A4CDD18BQ24650966-D767AEE2-AF4C-4508-B18D-FD8C9249BF3CQ24655779-B2712F83-168A-44D2-A780-D85E7021CC0FQ24672186-C91ED754-A999-4F8B-8215-76D2BF4C30F7Q26768699-C55E945A-F750-4CE1-8ED0-9FD146765C7DQ26795468-58A92B4B-75A9-46D0-8720-67E723D990D3Q26796132-70AA7623-558D-46B9-9027-90E560595F34Q26797242-970B5A0F-B8FD-4603-9B14-53D73DF46A7BQ26797344-EAD01E08-69A6-451F-B29F-D619542195FDQ26800120-B9FB771C-2AB9-4A2A-8836-AF6A5557779DQ26825059-35056505-72CF-4680-98FE-6EAFC5BA5E0BQ26827675-9300CF83-A21C-45D9-879C-6E2F4CF8B5C3Q26829512-CDEA7F60-7F2C-4F8B-84D6-E9A7154FCE71Q26865391-E8658E24-310B-46B3-AA11-2B7091457053Q26865650-BB32B911-C420-43D7-B229-372718ADE3C5Q26996330-9BC2DDDF-934F-412E-B14B-BA150B6071F5Q27003411-37B96AEC-03C8-45A5-BBAE-CB36A6DDB120Q27010174-7C70BBBB-A41F-47AD-A9EE-24788B67B670Q27023425-7F52BD1D-6E2B-41D7-B6FA-39DA901D0308Q27026700-55579E23-BC83-4312-9627-4DED86B22F03Q27308115-6FADD1D1-E13D-4CEB-BF5B-6AC5712D054EQ27310960-657A3822-7E33-4543-8405-1F99B9A2C548Q27314724-DA32A935-9CCF-4B03-AB12-98A66A6F3FCCQ27317219-78C4E61E-518A-44E3-B454-5AD3B93DFF34Q27318814-E5A23BA5-F7C7-43D0-ADC0-73FCB32058D5Q27332162-DD929E37-D8E7-4713-8796-9E1FBEE287E2Q27346402-8BAFC705-3BC0-4F0E-9189-9E6E54CB89FEQ27646525-B31FC66A-6DEA-4F31-86C0-D39510A18023Q27649921-506FBF11-63E4-4867-BF76-22DD6E66E901Q27658982-0F1613DB-6A54-4EB9-ADBF-96F526484F75Q27664892-AD519D2D-1EAB-4F3A-82CC-F80782E7139EQ27667172-04B2EB3B-3400-4C58-89E3-F3D2624C2698Q27670418-8CBF14DA-DA11-4C60-A5F1-3F0501A70C13Q27673052-F735DE0F-DF82-4FBB-ABE7-6AA6D67F156DQ27675443-6E7845D2-FCF9-47B0-88C4-DEEC934CE8C5Q27675463-4A051997-45AC-4B1A-8B20-8A31C1446353
P2860
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Exogenous and endogenous glyco ...... s during microbial infections.
@en
Exogenous and endogenous glyco ...... s during microbial infections.
@nl
type
label
Exogenous and endogenous glyco ...... s during microbial infections.
@en
Exogenous and endogenous glyco ...... s during microbial infections.
@nl
prefLabel
Exogenous and endogenous glyco ...... s during microbial infections.
@en
Exogenous and endogenous glyco ...... s during microbial infections.
@nl
P2093
P2860
P50
P356
P1433
P1476
Exogenous and endogenous glyco ...... s during microbial infections.
@en
P2093
Albert Bendelac
Carlos Cantu
Dapeng Zhou
David Walker
Jochen Mattner
Kristin L Debord
Luc Teyton
Nahed Ismail
Paul B Savage
P2860
P2888
P304
P356
10.1038/NATURE03408
P407
P577
2005-03-01T00:00:00Z
P5875
P6179
1011665502